Miguel
Burgos Lozano
Contratado Doctor
Universidad de Salamanca
Salamanca, EspañaUniversidad de Salamanca-ko ikertzaileekin lankidetzan egindako argitalpenak (2)
2017
-
Synthetic lethality interaction between aurora kinases and CHEK1 inhibitors in ovarian cancer
Molecular Cancer Therapeutics, Vol. 16, Núm. 11, pp. 2552-2562
-
Targeting basal-like breast tumors with bromodomain and extraterminal domain (BET) and polo-like kinase inhibitors
Oncotarget, Vol. 8, Núm. 12, pp. 19478-19490